Concepedia

Colin Millar

CM

Statistics

Publications

14

Citations

2.5K

H-Index

14

Active since

1996

Affiliations

William Harvey Research Institute(Current)

University of Oxford

University of Bristol

King's College London

University of Nottingham

Colin Millar is an author at William Harvey Research Institute specializing in medicine, pharmacotherapy, and primary outcome analysis.

Publications per year

1996–2024

14

Publications

14

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Renal Function and Outcome From Coronary Artery Bypass Grafting

Graham S. Hillis, Keith Buchan, Hussein El-Shafei et al. · Circulation · 2006 · 185 citations

Medicine, Cardiology, Surgery +17

1–5 of 14